TRADING UPDATES: Litigation Capital Management announces court win

Tue, 13th Jan 2026 22:04

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Tirupati Graphite PLC - London-based flake graphite producer, with projects in Madagascar and Mozambique - General meeting on January 6 passes resolution approving the sub-division of ordinary share of 2.5 pence into one new ordinary share of 1.0 pence and one deferred share of 1.5, which hold no voting or dividend rights. The new shares become effective on January 14, though Tirupati remains suspended. Further updates and the accounts from the year to March 31 and the half year to September 30 will be published in due course.

----------

Litigation Capital Management Ltd - asset manager focused on dispute financing - Announces positive development in the international arbitration claim against the Republic of Poland. In October, LCM secured two separate awards - one under the Energy Charter Treaty of GBP252 million plus interest; and one under the Australia-Poland Bilateral Investment Treaty of GBP183 million plus interest. Total damages cannot exceed GBP252 million plus interest as there is no double compensation. Poland has commenced set-aside proceedings in Singapore and London to attempt to annul the original awards. LCM said the Singapore court has rejected Poland's application. It expects an appeal likely to be resolved in the second half of 2026.

----------

Renalytix PLC - London-based diagnostics company - During the fourth quarter it successfully completes three additional health care provider clinical integrations in the United States with its kidneyintelX.dkd test. Says initial testing volumes have commenced across all sites. "These integrations enable the use of Renalytix's kidney disease testing solutions within each practice's existing clinical workflow. While each practice currently represents modest initial testing volumes, the company anticipates growing utilisation over time as adoption expands across their respective patient populations," company says. It adds: "The company continues to expand its electronic health care integrated testing with one-click ordering for ease of physician use."

----------

By Aidan Lane, Alliance News reporter

Comments and questions to newsroom@alliancenews.com